IL6 and temporal arteritis: Tocilizumab, an IL-6 inhibitor used in autoimmune diseases like rheumatoid arthritis and giant cell arteritis, was not administered to our patient cohort, thus precluding its evaluation in those with elevated IL-6 levels.